Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.

Google Services revenues for the quarter, up 10% from the previous year, thanks in large part to strong growth in Google ...

Eli Lilly, which first broke ground on its state-of-the-art Concord manufacturing facility ... professor of politics and history at Catawba College, who spoke to the crowd about the 2024 elections.

CNBC’s Jim Cramer on Friday told investors DeepSeek might not pose as serious a threat to Nvidia’s sales as many investors ...

The trending destinations Airbnb listed are defined by an increase in searches made by Gen Z travelers for trips this winter ...

Here, six house and techno artists provide a look into what it’s like being a tastemaker spinning at Time Warp. They discuss their favorite memories, why the event is special to them and more.

Lilly Endowment Inc. is supporting the renewal of Indiana K-12 educators through its 2025 Teacher Creativity Fellowship ...

Katherine repainted all of the downstairs rooms, added peel-and-stick wallpaper, installed peel-and-stick tiles in the ...

Maite Rodriguez and her husband gave their sick 6-year-old daughter a lifeline when their conceived a second child via IVF ...

Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...

Shares of Eli Lilly & Co. were headed for their worst day in nearly four years on Tuesday after the drugmaker provided a fourth-quarter revenue outlook that was below expectations, citing slower ...

2024 was an interesting year for pharmaceutical powerhouse Eli Lilly (NYSE: LLY). At one point, share prices had gained as much as 65% on the year. However, after a less-than-spectacular earnings ...